Top compounds associated with response to XKR7


Feature Type Standardized
Nominal ANOVA
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.23 3e-11
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 3e-11
mRNA PD-0325901 gCSI pan-cancer AAC -0.34 1e-10
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 2e-10
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 2e-10
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-10
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 4e-10
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.23 4e-10
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 5e-10
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-09
Download CSV